Evidence map›Paper›PMID 32541040›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

E2F1 sumoylation as a protective cellular mechanism in oxidative stress response.

Joshua D Graves, Yu-Ju Lee, Kang Liu, Gang Li, Fang-Tsyr Lin, Weei-Chin Lin

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. NKG2D Ligand Expression Induced by Oxidative Stress Mitigates Cutaneous Ischemia-Reperfusion Injury.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2023
    Article
  11. Article
  12. Article
  13. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joshua D GravesSection of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
Yu-Ju LeeSection of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0002-5319-7498
Kang LiuSection of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
Gang LiSection of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
Fang-Tsyr LinSection of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0001-5160-0047
Weei-Chin LinSection of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030; weeichil@bcm.edu.
Baylor College of Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
The ATM/E2F1 Pathway in DNA Damage and Growth ControlR01CA100857 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIN, WEEI-CHIN · 2004 to 2019
$4.8M
Novel therapeutics for targeting checkpoint dysfunction in cancerR01CA203824 · NCI · BAYLOR COLLEGE OF MEDICINE · PI FANG-TSYR LIN, WEEI-CHIN LIN · 2017 to 2026
$3.7M
Therapeutic Targeting of Oncogenic Stress in Cancer TreatmentR01CA138641 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LIN, WEEI-CHIN · 2010 to 2014
$1.5M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA100857NCI NIH HHS R01 CA138641NCI NIH HHS R01 CA203824NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIDDK NIH HHS T32 DK060445
6 · The paper itself

Abstract

Oxidative stress is a ubiquitous threat to all aerobic organisms and has been implicated in numerous pathological conditions such as cancer. Here we demonstrate a pivotal role for E2F1, a cell cycle regulatory transcription factor, in cell tolerance of oxidative stress. Cells lacking E2F1 are hypersensitive to oxidative stress due to the defects in cell cycle arrest. Oxidative stress inhibits E2F1 transcriptional activity, independent of changes in association with Rb and without decreasing its DNA-binding activity. Upon oxidative insult, SUMO2 is extensively conjugated to E2F1 mainly at lysine 266 residue, which specifically modulates E2F1 transcriptional activity to enhance cell cycle arrest for cell survival. We identify SENP3, a desumoylating enzyme, as an E2F1-interacting partner. Oxidative stress inhibits the interaction between E2F1 and SENP3, which leads to accumulation of sumoylated E2F1. SENP3-deficient cells exhibit hypersumoylation of E2F1 and are resistant to oxidative insult. High levels of SENP3 in breast cancer are associated with elevated levels of E2F targets, high tumor grade, and poor survival. Given the prevalence of elevated levels of SENP3 across numerous cancer types, the SENP3-E2F1 axis may serve as an avenue for therapeutic intervention in cancer.

Indexed as

Oxidative StressAmino Acid MotifsBreast NeoplasmsCysteine EndopeptidasesE2F1 Transcription FactorFemaleHumansProtein BindingSmall Ubiquitin-Related Modifier ProteinsSumoylationCysteine EndopeptidasesE2F1 Transcription FactorSENP3 protein, humanSmall Ubiquitin-Related Modifier ProteinsSUMO2 protein, humanE2F1oxidative stressSENP3SUMO2sumoylation

Identifiers

PMID32541040
PMCPMC7334650
OpenAlexW3034426037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.